Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/531633 stock hub

BOM/531633 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/531633is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.5B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/531633

In the news

Latest news · BOM/531633

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E15.4

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC13.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/531633 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

INR

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,853
Employees Change	166%
Employees Change Percent	9.84
Enterprise value	INR 11.2B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 13.5B
Price	INR 676
Price currency	INR
Rev Per Employee	3,518,271.45x
Sic	2834
Symbol	bom/531633
Website	https://www.lincolnpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.49%
EV Earnings	12.78x
EV/EBIT	12.95x
EV/EBITDA	11.09x
EV/Sales	1.72x
P/B ratio	1.89x
P/E ratio	15.42x
P/S ratio	2.08x
PE Ratio10 Y	11x
PE Ratio3 Y	12.86x
PE Ratio5 Y	11.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.29%
EBITDA Margin	15.51%
Gross margin	52.76%
Gross Profit	INR 3.4B
Gross Profit Growth	11.45%
Gross Profit Growth Q	15.97%
Gross Profit Growth3 Y	9.95%
Gross Profit Growth5 Y	10.16%
Net Income	INR 878.3M
Net Income Growth	-1.72%
Net Income Growth Q	37.7%
Net Income Growth3 Y	7.17%
Net Income Growth5 Y	8.43%
Pretax Margin	17.67%
Profit Margin	13.47%
Profit Per Employee	INR 474,011
Roa5y	9.62
Roe5y	16.26
ROIC	13.66
Roic5y	18.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.53%
Cagr15y	23.07%
Cagr1y	18.56%
Cagr20y	16.59%
Cagr3y	20.46%
Cagr5y	18.95%
Div CAGR10	6.05%
Div CAGR3	6.27%
Div CAGR5	-9.71%
EPS Growth	-1.7
EPS Growth Q	37.71
EPS Growth3 Y	7.17
EPS Growth5 Y	8.4
Revenue Growth	9.1x
Revenue Growth Q	13.49x
Revenue Growth3 Y	9.22x
Revenue Growth5 Y	9.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.3B
Debt	INR 668,000
Debt EBITDA	INR 0
Debt Equity	INR 0
Equity	INR 7.2B
Interest Coverage	396.9
Net Cash	INR 2.3B
Net Cash By Market Cap	INR 17.12
Net Cash Growth	18.26%
Net Debt EBITDA	INR -2.29
Net Debt Equity	INR -0.32
Tangible Book Value	INR 7.2B
Tangible Book Value Per Share	INR 357
WACC	6.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1.8
Dividend Years	20
Dividend Yield	0.27%
Ex Div Date	2025-09-12
Last Dividend	INR 1.8
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	361.57%
1Y total return	18.54%
200-day SMA	544.4
3Y total return	74.81%
50-day SMA	610.8
50-day SMA vs 200-day SMA	50over200
5Y total return	138.05%
All Time High	975
All Time High Change	-31.24%
All Time High Date	2024-12-09
All Time Low	14.75
All Time Low Change	4,445.42%
All Time Low Date	2008-11-19
ATR	29.66
Beta	0.4
Beta1y	0.62
Beta2y	0.64
Ch YTD	38.75
High	684
High52	731.5
High52 Date	2026-04-29
High52ch	-7.59%
Low	665
Low52	440
Low52 Date	2026-02-04
Low52ch	53.65%
Ma50ch	9.77%
Price vs 200-day SMA	23.16%
RSI	63.96
RSI Monthly	58.55
RSI Weekly	67.76
Sharpe ratio	0.53x
Sortino ratio	1.14
Total Return	0.28%
Tr YTD	38.75
Tr15y	2,151.32%
Tr1m	22.02%
Tr1w	4.55%
Tr3m	45.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 866.5M
Operating Income Growth	6.85
Operating Income Growth Q	-2.76
Operating Income Growth3 Y	2.04
Operating Income Growth5 Y	3.43
Operating margin	13.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,264,662%
Shares Insiders	48.07%
Shares Institutions	0.53%
Shares Out	20,029,728
Shares Qo Q	0.02%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,702.3x
Bv Per Share	357.5
Ch10y	337.9
Ch15y	1,860.4
Ch1m	22.02
Ch1w	4.55
Ch1y	18.16
Ch20y	1,408.3
Ch3m	45.69
Ch3y	73.33
Ch5y	134
Ch6m	27.57
Change	0.83%
Change From Open	1.05
Close	670.5
Days Gap	-0.22
Depreciation Amortization	144,853,000
Dollar Volume	2,279,472
Earnings Date	2026-05-21
EBIT	INR 866.5M
EBITDA	INR 1B
EPS	INR 43.85
F Score	2
Fiscal Year End	March
Founded	1,979
Graham Number	593.86436
Graham Upside	-11.42
Income Tax	INR 273.3M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2009-03-19
Last Split Type	Reverse
Lynch Fair Value	INR 370
Lynch Upside	-44.85
Ma150	542.4
Ma150ch	23.62%
Ma20	622.4
Ma20ch	7.72%
Next Earnings Date	2026-05-21
Open	669
Payment Date	2025-10-30
Position In Range	58.05
Price Date	2026-05-08
Price EBITDA	INR 13.39
Ptbv Ratio	1.89
Relative Volume	0.32x
Revenue	6,519,357,000x
Tax By Revenue	4.19x
Tax Rate	23.73%
Tr20y	2,052.31%
Tr6m	27.57%
Volume	3,372

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/531633 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$1.80 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-9.7%

0 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-09-12

Performance

BOM/531633 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/531633?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+48.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

BOM/531633 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.0

Neutral momentum band

Price vs 200-day MA

+23.2%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/531633

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/531633 stock rating?

bom/531633 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/531633 analysis?

The full report lives at /stocks/bom/531633/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/531633?

The latest report frames bom/531633 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/531633 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.